These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6831687)

  • 1. Development and analytical performance of automated tests for antithrombin III and plasminogen on the Du Pont aca analyzer.
    Perry JF; Siefring GE; Reider MC; Coleman PL; Wehrly JA
    Clin Chem; 1983 Apr; 29(4):609-13. PubMed ID: 6831687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and analytical performance of a functional assay for fibrinogen on the Du Pont aca analyzer.
    Siefring GE; Riabov DK; Wehrly JA
    Clin Chem; 1983 Apr; 29(4):614-7. PubMed ID: 6187499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of an automated assay of effective heparin activity in plasma.
    Pierson-Perry JF; Obzansky DM; Mizzer JP
    Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automation of plasma antithrombin III assays.
    Holmes EW; Fareed J; Bermes EW
    Clin Chem; 1981 Jun; 27(6):816-8. PubMed ID: 7237757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 9. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III and fibrinogen measurement using the Du Pont aca discrete clinical analyzer--a reply.
    Roche PA
    Am J Clin Pathol; 1984 Feb; 81(2):276-7. PubMed ID: 6695864
    [No Abstract]   [Full Text] [Related]  

  • 12. Two automated methods for plasma antithrombin III compared, and the clinical significance of the results.
    Prellwitz W; Schmitt KF; Machner M; Schuster CJ; Weilemann L
    Clin Chem; 1982 Nov; 28(11):2249-53. PubMed ID: 6812990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate.
    Hitomi Y; Kanda T; Niinobe M; Fujii S
    Clin Chim Acta; 1982 Mar; 119(3):157-64. PubMed ID: 6461438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III.
    Gram J; Jespersen J
    Clin Chem; 1989 Jan; 35(1):52-5. PubMed ID: 2910581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of high-performance liquid chromatography to the characterization of the interactions of heparin with antithrombin III and thrombin.
    Lahiri B; Danishefsky I
    Anal Biochem; 1983 Feb; 129(1):46-50. PubMed ID: 6859531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.